Prevention of peritoneal adhesions with aprotinin (trasylol).
An objective assessment of intraperitoneal trasylol in the prevention of abdominal adhesions in 20 patients has shown that Trasylol resulted in a marked reduction in adhesions in 16 patients who underwent 'second look' procedures. No side-effects were noted and all wounds healed without complications.
D000293:Adolescent; D000328:Adult; D000368:Aged; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008297:Male; D008875:Middle Aged; D010537:Peritoneum; D011183:Postoperative Complications / Q000517:prevention & control*; D000267:Tissue Adhesions
D007611:Aprotinin